Candesartan is an angiotensin II receptor blocker widely used for hypertension and as adjunct therapy in heart failure with reduced ejection fraction. Simson Pharma's Candesartan reference standard and impurities support the high-volume compendial testing this established ARB requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Candesartan Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.